Both in Pharmaceuticals
XBiotech vs Xilio Therapeutics
Over the past year XBIT returned −16.7% and XLO returned −30.2%; their daily moves had a correlation of -0.00.
XBIT −16.7% XLO −30.2%Growth of $1, one year, split-adjusted
| Metric | XBIT | XLO |
|---|---|---|
| Price | $1.99 | $8.01 |
| Market cap | $60.7M | $52.7M |
| Today | +7.57% | 0.00% |
| 1 month | −8.7% | −10.4% |
| 6 months | −21.0% | +2.8% |
| Year to date | −16.7% | −10.6% |
| 1 year | −22.6% | −31.1% |
| Revenue growth (YoY) | — | +131.2% |
| Gross margin | — | 100.0% |
| Net margin | — | −34.1% |
| P/E (TTM) | — | — |
| Price / sales | — | 0.8× |
| Net cash | $109.5M | $136.0M |
| Dividend yield | — | — |
| Volatility (60d) | 34.2% | 33.2% |
| Short % of float | 1.8% | 10.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).